Chinmayi Himanshuroy Vyas (Kelvin Yi Chong Teo)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Fluorescence Imaging

Age Related Macular Degeneration

Top Venues

Eye (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher Ziyu Sun, Shaun Sebastian Khung Peng Sim, Chinmayi Himanshuroy Vyas, Pooi Wah Lott, Rubamalar Gunatheesan, Kelvin Yi Chong Teo, Chui Ming Gemmy Cheung
Infographic: non-ICGA imaging for polypoidal choroidal vasculopathy (PCV) - Asia-Pacific Ocular Imaging Society PCV workgroup report 1 & 2. Eye (London, England) 36 (6) (2022)
Shaun Sebastian Khung Peng Sim, Chinmayi Himanshuroy Vyas, Rubamalar Gunatheesan, Pooi Wah Lott, Christopher Ziyu Sun, Kelvin Yi Chong Teo, Gemmy Cheung Chui Ming
Infographic: "Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)". Eye (London, England) 36 (6) (2022)
Chinmayi Himanshuroy Vyas, Pooi Wah Lott, Rubamalar Gunatheesan, Shaun Sebastian Khung Peng Sim, Christopher Ziyu Sun, Kelvin Yi Chong Teo, Gemmy Cheung Chui Ming
Infographic: Everest II study "Which is superior? Combination therapy or monotherapy for polypoidal choroidal vasculopathy (PCV) treatment". Eye (London, England) 36 (6) (2022)
Chinmayi Himanshuroy Vyas, Gemmy Cheung Chui Ming, Colin Tan, Caroline Chee, Kelly Wong, Janice Marie N Jordan-Yu, Tien-Yin Wong, Anna Tan, Beau Fenner, Shaun Sim, Chinmayi Himanshuroy Vyas
Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy. BMJ open 11 (7) (2021)